National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting

---
identifier: "/us/fr/03-4060"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "03-4060"
section_name: "National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting"
positive_law: false
currency: "2003-02-21"
last_updated: "2003-02-21"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-4060"
document_type: "notice"
publication_date: "2003-02-21"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "68 FR 8513"
fr_volume: 68
---


#  National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following Federal advisory committee meeting.

*Name:* National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE).

*Times and Dates:* 8:30 a.m.-4 p.m., March 13, 2003. 8:30 a.m.-11:45 a.m., March 14, 2003.

*Place:* Doubletree Hotel Atlanta/Buckhead, 3342 Peachtree Road, NE.,  Atlanta, Georgia 30326, telephone 404/231-1234, fax 404/231-3112.

*Status:* Open to the public, limited only by the space available. The meeting room accommodates approximately 65 people.

*Purpose:* The Secretary is authorized by the Public Health Service Act, Section 399G, (42 U.S.C. Section 280f, as added by Public Law 105-392) to establish a National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect to:

(1) Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effect (FAE) research, programs and surveillance; and (2) to otherwise meet the general needs of populations actually or potentially impacted by FAS and FAE.

*Matters to Be Discussed:* Agenda items include: an update from the National Center on Birth Defects and Developmental Disabilities Scientific Working Group on Diagnostic Guidelines for FAS and Alcohol-Related Neurodevelopmental Disabilities (ARND); an update on activities from the Interagency Coordinating Committee on Fetal Alcohol Syndrome; new research and program updates from the CDC and other Federal agencies; and working group updates. Additional agenda items include: task force discussions on the use of the term fetal alcohol spectrum disorders: What is it? When is it appropriate to use it?; provider education and FAS prevention; development of a clear message for pediatricians, nurses, and other providers: how the FAS diagnosis will benefit the child and family; future topics, and scheduling the next meeting.

Agenda items are subject to change as priorities dictate.

**CONTACT PERSON FOR MORE INFORMATION:**

R. Louise Floyd, DSN, RN, Designated Federal Official, National Center on Birth Defects and Developmental Disabilities, CDC, 4700 Buford Highway, NE, (F-49), Atlanta, Georgia 30333, telephone 770/488-7372, fax 770/488-7361.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR.

Dated: February 13, 2003.

Joseph E. Salter,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.